Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALMS | Alumis Inc | Healthcare | 2,386,529.0 | $52.6M | 4.06% | -15K | -0.6% | $22.03 | +0.6% |
| 2 | CRVS | Corvus Pharmaceuticals Inc | Healthcare | 1,674,875.0 | $24.5M | 1.89% | -1.1M | -39.0% | $14.63 | -10.6% |
| 3 | QURE | Uniqure NV | Healthcare | 1,369,231.0 | $22.4M | 1.73% | -12K | -0.9% | $16.35 | +50.5% |
| 4 | NTRA | Natera Inc | Healthcare | 93,074.0 | $18.6M | 1.44% | -477.0 | -0.5% | $199.99 | +1.9% |
| 5 | — | Climb Bio Inc | — | 2,593,439.0 | $17.8M | 1.37% | -78K | -2.9% | $6.85 | — |
| 6 | — | Bright Minds Biosciences Inc | — | 212,175.0 | $15.5M | 1.20% | -18K | -7.8% | $72.97 | — |
| 7 | HOWL | Werewolf Therapeutics, Inc. | Healthcare | 1,208,810.0 | $1.0M | 0.08% | -185K | -13.3% | $0.83 | -49.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%